These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3055976)

  • 21. Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients.
    Lemieux I; Houde I; Pascot A; Lachance JG; Noël R; Radeau T; Després JP; Bergeron J
    Kidney Int; 2002 Nov; 62(5):1839-47. PubMed ID: 12371987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia.
    Hricik DE; Mayes JT; Schulak JA
    Am J Kidney Dis; 1991 Sep; 18(3):353-8. PubMed ID: 1882828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
    Vanhaecke J; Van Cleemput J; Van Lierde J; Daenen W; De Geest H
    Transplantation; 1994 Jul; 58(1):42-5. PubMed ID: 8036706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the development of hypercholesterolemia after cardiac transplantation.
    Kubo SH; Peters JR; Knutson KR; Hertz MI; Olivari MT; Bolman RM; Hunninghake DB
    Am J Cardiol; 1992 Aug; 70(4):520-6. PubMed ID: 1642192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.
    Hedman M; Neuvonen PJ; Neuvonen M; Holmberg C; Antikainen M
    Clin Pharmacol Ther; 2004 Jan; 75(1):101-9. PubMed ID: 14749696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
    Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
    J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized study comparing deflazacort and prednisone in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
    J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
    Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G
    Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of hypercholesterolemia after cardiac transplantation.
    Stamler JS; Vaughan DE; Rudd MA; Mudge GH; Kirshenbaum J; Young P; Alexander RW; Loscalzo J
    Am J Cardiol; 1988 Dec; 62(17):1268-72. PubMed ID: 3057854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid abnormalities in stable liver transplant recipients--effects of cyclosporin, tacrolimus, and steroids.
    Fernández-Miranda C; Guijarro C; de la Calle A; Loinaz C; Gonzalez-Pinto I; Gómez-Izquierdo T; Larumbe S; Moreno E; del Palacio A
    Transpl Int; 1998; 11(2):137-42. PubMed ID: 9561680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients.
    Azrolan N; Brown CD; Thomas L; Hayek T; Zhao ZH; Roberts KG; Scheiner C; Friedman EA
    Arterioscler Thromb; 1994 Sep; 14(9):1393-8. PubMed ID: 8068598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cyclosporine therapy on plasma lipoprotein levels.
    Ballantyne CM; Podet EJ; Patsch WP; Harati Y; Appel V; Gotto AM; Young JB
    JAMA; 1989 Jul; 262(1):53-6. PubMed ID: 2733125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation.
    Siirtola A; Antikainen M; Ala-Houhala M; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
    J Heart Lung Transplant; 2004 Apr; 23(4):418-26. PubMed ID: 15063401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine.
    Morales JM; Hartmann A; Walker R; Arns W; Senatorski G; Grinyó JM; Shoker A; Wilczek H; Jamieson NV; Lelong M; Brault Y; Burke JT; Scarola JA;
    Transplant Proc; 2009; 41(6):2339-44. PubMed ID: 19715914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Gleeson MP; Moriguchi JD; Kawata N; Minkley R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1995; 14(5):963-7. PubMed ID: 8800734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.